Mind Body Intervention for Chronic Migraine Headaches

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorBeth Israel Deaconess Medical Center

About this trial

The goal of this exploratory study is to test a mind-body interventional approach for the treatment of chronic migraines. The main goal is to obtain feasibility information on the protocol which has been used in other similar conditions. We will also evaluate multiple measurement tools in order to optimize a follow-up pilot study evaluating the impact of the protocol on migraines.

Eligibility criteria

Qualifiers

Adult (≥ 18 years of age)

Previously diagnosed with migraine headache based on ICHD-3 beta criteria 91

A score of ≥ 50 on the Headache Impact Test-6 self-report survey (moderate impact) 92

Presence of migraine headaches at least 5 days per month

Disqualifiers

Known history or suspicion of headaches due to organic cause (e.g. cancer, sinus infection, head trauma, cerebrovascular disease)

Diagnosis of other chronic pain syndromes that may cloud assessments (e.g. fibromyalgia, chronic idiopathic neck pain)

Diagnosis of cognitive impairment or dementia

Active addiction disorder, e.g. cocaine or IV heroin use, that would interfere with study participation

Trial design

Treatments tested in this trial

  • Mind-Body Intervention

Treatment groups

10 Participants
are divided into 1 treatment group